Age Related Macular Degeneration News and Research

RSS

Microglia play protective role in response to retinal detachment, shows study

A research team at Massachusetts Eye and Ear has shown that microglia, the primary immune cells of the brain and retina, play a protective role in response to retinal detachment.

19 Jun 2018

PanOptica doses first patient in Phase 1/2 dose-ranging clinical trial of PAN-90806

PanOptica, Inc., a private biopharmaceutical company focused on developing innovative ophthalmology therapies, today announced that the Company has dosed the first patient in a Phase 1/2 dose-ranging clinical trial of PAN-90806, a once-daily topical eye drop formulation of a small-molecule anti-vascular endothelial growth factor (anti-VEGF) for the treatment of neovascular eye diseases.

22 May 2018

New lab-on-a-chip device shows promise in treating retinal diseases

Houston Methodist researchers developed a new lab-on-a-chip technology that could quickly screen possible drugs to repair damaged neuron and retinal connections, like what is seen in people with macular degeneration or who've had too much exposure to the glare of electronic screens.

10 May 2018

New studies show potential for using genetic information to create personalized vision care

Two new studies demonstrate potential future opportunities to use genetic information to treat vision conditions. The new studies are being presented at the 2018 Annual Meeting of the Association for Research in Vision and Ophthalmology in Honolulu, Hawaii, Sunday, April 29 – Thursday, May 3.

30 Apr 2018

Healthy diet can be key to preventing age-related macular degeneration

There is no permanent cure for age-related macular degeneration, the leading cause of vision loss in adults ages 50 and older affecting about 10 million Americans.

10 Apr 2018

Aging immune cells increase risk for macular degeneration

As people age, their immune systems age, too. And new research at Washington University School of Medicine in St. Louis suggests that aging immune cells increase the risk for age-related macular degeneration, a major cause of blindness in the United States.

5 Apr 2018

First-in-human clinical trial of retinal implant to treat dry AMD

Age-related macular degeneration (AMD) affects more than 1.75 million individuals in the United States. Because the population is aging, that number will increase to almost 3 million by 2020. Between 80 and 90 percent of cases in this country are the dry version of the condition, for which no effective treatment exists.

5 Apr 2018

New trial to test stem cell-based retinal implant for dry age-related macular degeneration

Physicians and researchers at the USC Roski Eye Institute have collaborated with other California institutions to show that a first-in-kind stem cell-based retinal implant is feasible for use in people with advanced dry age-related macular degeneration.

4 Apr 2018

Immune cells can repopulate in the retina after elimination, mice study shows

Immune cells called microglia can completely repopulate themselves in the retina after being nearly eliminated, according to a new study in mice from scientists at the National Eye Institute.

21 Mar 2018

Stem cell-derived ocular cells treat severe AMD

In July 2015, 86-year-old Douglas Waters developed severe age-related macular degeneration (AMD). He struggled to see things clearly, even when up close.

19 Mar 2018

New NIH study aims to identify biomarkers of AMD progression

A new clinical study led by the National Eye Institute, part of the National Institutes of Health, will follow 500 people over five years to learn more about the natural history of early age-related macular degeneration.

26 Feb 2018

Fight for Sight awards new grants for 13 vital eye research projects

Fight for Sight, the leading eye research charity, has awarded grants totaling over £180,000 for thirteen vital research projects in partnership with nine different organizations.

2 Feb 2018

Pixium Vision announces successful implantation and activation of PRIMA Bionic Vision System

Pixium Vision (FR0011950641 - PIX), a company developing innovative bionic vision systems to enable patients who have lost their sight to lead more independent lives, announces today the world’s first successful human implantation and activation of PRIMA, its new generation miniaturized wireless photovoltaic sub-retinal implant, in a patient with severe vision loss from atrophic dry Age-related Macular Degeneration (AMD).

27 Jan 2018

Sex steroid hormone fluctuations may have direct effects on eye physiology and AMD

Gender-based differences may influence several ocular conditions, suggesting that fluctuations in sex steroid homeostasis may have direct effects on eye physiology and the pathogenesis of conditions like Age-Related Macular Degeneration.

18 Jan 2018

New retinal imaging scanner may one day revolutionize eye care

SFU engineering science professor Marinko Sarunic has developed a high resolution retinal imaging scanner that will one day revolutionize eye care, helping ophthalmologists diagnose eye diseases before vision loss occurs.

21 Dec 2017

Retinal diseases could be treated by ophthalmic drops instead of intraocular injections

The Spanish firm Sylentis has developed a compound to treat diseases of the retina, such as age-related macular degeneration and diabetic retinopathy, which will be administered by ophthalmic drops instead of intraocular injections.

12 Dec 2017

Improving Healthcare in the Community through Eye Examinations

Paul Morris is the Director of Professional Advancement for Specsavers Opticians in the UK and Ireland. The role involves furthering clinical scope, professional services, standards, training and forming future strategy for the group. He previously held the role of Director of Optometry Advancement.

From Specsavers 1 Dec 2017

Fish oil component provides long-term preconditioning protection for vision cells

A team of LSU Health New Orleans scientists discovered that a component of fish oil not only protects cells critical to vision from potentially lethal initial insults, but also from those that occur in the future.

1 Dec 2017

Researchers discover critical trigger for leading form of vision loss

In a major step forward in the battle against macular degeneration, the leading cause of vision loss among the elderly, researchers at the University of Virginia School of Medicine have discovered a critical trigger for the damaging inflammation that ultimately robs millions of their sight.

27 Nov 2017

Study finds huge decline in risk for AMD in Baby Boom and later generations

The risk of developing age-related macular degeneration is much less in the Baby Boom (1946-1964) and later generations than in earlier generations, for unclear reasons.

16 Nov 2017